Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? - PubMed (original) (raw)
. 1984 Mar;308(5954):69-72.
doi: 10.1038/308069a0.
- PMID: 6700714
- DOI: 10.1038/308069a0
Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
A P Albino et al. Nature. 1984 Mar.
Abstract
Variability in the phenotype of cells comprising individual tumours is a striking feature of animal and human cancer and is generally referred to as tumour heterogeneity. Studies of clonally derived cell populations from tumours that originated presumably from a single transformed cell have shown that tumours are made up of cells that differ in a variety of traits, including drug resistance, antigen expression and metastatic potential. The origin and maintenance of tumour heterogeneity are unclear, but mutational and epigenetic mechanisms are thought to be involved. Here we report the results of a search for transforming genes in human melanoma which have raised the possibility that ras gene activation follows the same variable pattern as other traits involved in tumour heterogeneity. DNA from 4 of 30 melanoma cell lines yielded transforming ras genes in the NIH/3T3 assay. Of five cell lines originating from separate metastatic deposits of a single patient, only one contained activated ras, indicating heterogeneity in ras activation in this case and suggesting that ras activation was not involved in tumour initiation or maintenance in this patient.
Similar articles
- A novel transforming gene in a human malignant melanoma cell line.
Padua RA, Barrass N, Currie GA. Padua RA, et al. Nature. 1984 Oct 18-24;311(5987):671-3. doi: 10.1038/311671a0. Nature. 1984. PMID: 6090953 - Transforming activity of human melanoma DNA.
Sekiya T, Hirohashi S, Nishimura S, Sugimura T. Sekiya T, et al. Gan. 1983 Dec;74(6):794-7. Gan. 1983. PMID: 6667830 - [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
Kniazev PG, Schäfer R, Willecke K, Seits IF. Kniazev PG, et al. Vopr Onkol. 1985;31(6):77-85. Vopr Onkol. 1985. PMID: 4024551 Russian. - The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS. Cooper CS. Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333. Environ Health Perspect. 1991. PMID: 1685444 Free PMC article. Review. - Molecular genetics of metastasis.
Tarin D. Tarin D. Ciba Found Symp. 1988;141:149-69. doi: 10.1002/9780470513736.ch9. Ciba Found Symp. 1988. PMID: 3075933 Review.
Cited by
- NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.
Fedorenko IV, Gibney GT, Smalley KS. Fedorenko IV, et al. Oncogene. 2013 Jun 20;32(25):3009-18. doi: 10.1038/onc.2012.453. Epub 2012 Oct 15. Oncogene. 2013. PMID: 23069660 Free PMC article. Review. - Cyclobutane thymine dimers in a ras proto-oncogene hot spot activate the gene by point mutation.
Kamiya H, Murata N, Murata T, Iwai S, Matsukage A, Masutani C, Hanaoka F, Ohtsuka E. Kamiya H, et al. Nucleic Acids Res. 1993 May 25;21(10):2355-61. doi: 10.1093/nar/21.10.2355. Nucleic Acids Res. 1993. PMID: 8389438 Free PMC article. - The 1984 Walter Hubert lecture. Activation of transforming genes in neoplasms.
Cooper GM. Cooper GM. Br J Cancer. 1984 Aug;50(2):137-42. doi: 10.1038/bjc.1984.155. Br J Cancer. 1984. PMID: 6380552 Free PMC article. Review. - H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system.
Leon J, Kamino H, Steinberg JJ, Pellicer A. Leon J, et al. Mol Cell Biol. 1988 Feb;8(2):786-93. doi: 10.1128/mcb.8.2.786-793.1988. Mol Cell Biol. 1988. PMID: 3127691 Free PMC article. - Activation of N-ras in a human melanoma cell line.
Padua RA, Barrass NC, Currie GA. Padua RA, et al. Mol Cell Biol. 1985 Mar;5(3):582-5. doi: 10.1128/mcb.5.3.582-585.1985. Mol Cell Biol. 1985. PMID: 3887133 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical